Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Gland Pharma
This Pharma Stock Has Slumped 10% In 30 Days, But Analysts See 30% Rally Ahead
After a strong run in 2023, shares of Gland Pharma have had a slow start to 2024. In the last 30 days, the stock has gone down around 10%. Analysts at Motilal Oswal think that the stock is trading at an attractive valuation.
This Pharma Stock Has Slumped 10% In 30 Days, But Analysts See 30% Rally Ahead
